The pandemic has hugely amplified the importance of measuring health outcomes – both in Europe and beyond. Which steps can health leaders take to embed this in the heart of post-COVID systems and policies? A new Science|Business guide explores the options.
The pandemic is causing huge disruption to the EU’s flagship research programme. Which steps can Europe take to help its R&D communities navigate through the crisis? A new Science|Business report explores the options
In February 2020, scientists, clinicians, patients and industry representatives met in Stockholm to discuss how governments, education systems, and new technologies can help treat and prevent mental health problems. The roundtable was the latest in the Science|Business Healthy Measures series.
For the innovators behind new biodegradable, recyclable products, the EU’s biggest-ever climate and environment battle plan opens up opportunities for growth
The kinds of skills needed to make artificial intelligence work in the real economy may be closer to plumbing than rocket science, say experts at Science|Business roundtable
As the globalisation of research proceeds apace, the nascent European Open Science Cloud (EOSC) will need to be connected with similar initiatives elsewhere in the world. This paper explores how open science is developing around the world and the ramifications for EOSC and research in Europe.
At a Science|Business meeting in Trondheim, clinical specialists, tech experts, patients and policymakers debated how to use health registry data to achieve better patient outcomes
France, Canada and others are pushing for some international ‘rules of the road’ for artificial intelligence. But differing cultures, industries and policies complicate efforts to develop a global approach, say international experts at a Science|Business conference
